Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Riccardo Corbellari
Observed name:
Corbellari, Riccardo
Institution:
University of Trento
Observed institutions:
University of Trento,
Philochem (Switzerland)
ORCID:
0000-0001-6126-5641
Observed ORCID:
0000-0001-6126-5641
OpenAlex ID:
A5039170943
Proteome‐minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform
2021
·
Ilaria Zanella
, Enrico König
, et al.
·
Journal of Extracellular Vesicles
·
75
PDF
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models
2018
·
Alberto Grandi
, Laura Fantappiè
, et al.
·
Frontiers in Oncology
·
39
PDF
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
2022
·
Lisa Nadal
, Frederik Peissert
, et al.
·
Journal for ImmunoTherapy of Cancer
·
31
PDF
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles
2023
·
Elena Caproni
, Riccardo Corbellari
, et al.
·
Cancers
·
29
PDF
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo
2020
·
Tiziano Ongaro
, Baptiste Gouyou
, et al.
·
Oncotarget
·
24
PDF
A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis
2021
·
Riccardo Corbellari
, Marco Stringhini
, et al.
·
Molecular Cancer Therapeutics
·
23
The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors
2020
·
Riccardo Corbellari
, Lisa Nadal
, et al.
·
Anti-Cancer Drugs
·
19
PDF
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo
2020
·
Lisa Nadal
, Riccardo Corbellari
, et al.
·
mAbs
·
18
PDF
Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens
2023
·
Lorenzo Croia
, Giulia Boscato Sopetto
, et al.
·
Membranes
·
17
PDF
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
2023
·
Alberto Grandi
, Michele Tomasi
, et al.
·
Vaccines
·
14
PDF
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2
2023
·
Silvia Tamburini
, Yueru Zhang
, et al.
·
Vaccines
·
13
PDF
Adapting Neutralizing Antibodies to Viral Variants by Structure‐Guided Affinity Maturation Using Phage Display Technology
2023
·
Frederik Peissert
, Mattia Pedotti
, et al.
·
Global Challenges
·
9
PDF
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
2023
·
Alberto Grandi
, Michele Tomasi
, et al.
·
Research Square
·
6
PDF
Tripokin: A multi‐specific immunocytokine for cancer immunotherapy
2024
·
Eleonora Prodi
, Riccardo Corbellari
, et al.
·
International Journal of Cancer
·
2
PDF
Abstract 1877: Tripokin: potential best-in-class for tumor targeted interleukin-2 (IL2) potentiated by tumor necrosis factor (TNF)
2023
·
Eleonora Prodi
, Riccardo Corbellari
, et al.
·
Cancer Research
·
1
1093 A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer
2022
·
Lisa Nadal
, Frederik Peissert
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Type 2 Inflammation in Airway Diseases: Eosinophilic Bronchiectasis as an Emerging Phenotype
2026
·
Carlo Lombardi
, Marcello Cottini
, et al.
·
Clinical Reviews in Allergy & Immunology
Cytokine-bearing Bacterial Outer Membrane Vesicles with Empowered Efficacy in Intratumoral Immunotherapy
2026
·
Riccardo Corbellari
, Michele Tomasi
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain
2025
·
Michele Tomasi
, Lorenzo Croia
, et al.
·
Frontiers in Immunology
PDF
Data from A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis
2023
·
Riccardo Corbellari
, Marco Stringhini
, et al.
Supplementary Figures S1-S10 from A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis
2023
·
Riccardo Corbellari
, Marco Stringhini
, et al.
Show more works
View as search
Works count:
22
Citation count:
321
H-index:
11
I10-index:
11
Year
Topic
Type